![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Active Filter(s):
Details:
Quest will add the Enemeez and DocuSol brands of bowel care products, to its' portfolio of self-care products.
Lead Product(s): Docusate Potassium
Therapeutic Area: Gastroenterology Product Name: Enemeez
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Quest Products, LLC
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition June 24, 2020